<DOC>
	<DOCNO>NCT00730327</DOCNO>
	<brief_summary>Safety effectiveness BIB® System conjunction behavior modification program compare behavior modification program alone weight loss obese subject .</brief_summary>
	<brief_title>A Study BioEnterics® Intragastric Balloon ( BIB® ) System Assist Weight Management Obese Subjects</brief_title>
	<detailed_description />
	<criteria>Have BMI ≥ 30 ≤ 40 ; Be male female , 18 65 year age , inclusive ; Have history obesity ( BMI ≥ 30 kg/m2 ) least 2 year fail conservative weightreduction alternative , supervise diet , exercise behavioral modification program ; Be willing commit longterm low calorie ( 10001500 calories/day ) supervise diet ; Have reasonable weight loss expectation ( accept goal lose 15 % body weight 26 week ) ; Be able follow requirement outline protocol , include comply visit schedule behavioral modification program , willing undergo protocolspecific procedure , e.g. , endoscopy , local sedation , general anesthesia , upper gastrointestinal radiography ( UGI ) , electrocardiography ( EKG ) , gastric motility testing , and/or clinical laboratory testing ; Must willing take prescribe proton pump inhibitor ( PPIs ) medication prescribe investigator ; Be able provide write informed consent authorization use release Health Research Study Information ; Be willing use contraception ( e.g. , birth control pill , condom , abstinence ) avoid pregnancy study female childbearing potential . Any surgery foregut exclude uncomplicated cholecystectomy History symptom gastrointestinal ( GI ) surgery ( exclude uncomplicated appendectomy ) , GI obstruction , adhesive peritonitis , and/or hiatal hernia ( &gt; /= 2 cm ) ; A patulous pyloric channel ; History symptom esophageal GI motility disorder ( &lt; 40 % ) patient particularly susceptible development esophagitis ; History previous symptom delay Gastric Emptying ( GE ) and/or delay GE document previously perform gastric scintigraphy study another previously perform diagnostic study UGI xray series ; Current symptom delay GE ; A history myocardial infarction previous 6 month : New York Heart Associate ( NYHA ) Class III IV ( heart failure ) cardiac arrhythmia ( e.g. , atrial fibrillation ) ; Anemia define hemoglobin value females &lt; 11.3 g/dl male &lt; 13.0 g/dl ; History symptom varix , bowel obstruction , congenital acquire GI anomaly ( e.g. , atresia , stenosis , stricture , and/or diverticulum ) , severe renal , hepatic , and/or pulmonary disease ; History symptom inflammatory bowel disease , Crohn 's disease Ulcerative Colitis ; History symptom uncontrolled unstable thyroid disease ; Subjects positive test Helicobacter pylorus ( H.p . ) screening ; subject may participate study , prior randomization , treat pharmacological regimen design eradicate H.p . subsequently negative H.p . breath test indicate H.p . eradicate History symptom past 24 month significant irritable bowel syndrome , peritonitis , active esophagitis , gastritis and/or duodenitis , gastric duodenal ulceration , GI hemorrhage , GI bleeding ; Type I diabetes ; Placement previous intragastric balloon similar device ; Ongoing treatment anticoagulant , steroid , aspirin , nonsteroidal antiinflammatory drug ( NSAIDS ) , medication know gastroduodenal mucosal irritant reduce GI motility , and/or unwillingness discontinue use concomitant medication ; Concomitant use prescription , nonprescription , overthecounter weight loss medication supplement time study ; Evidence untreated psychiatric eating disorder , major depression , schizophrenia , substance abuse , binge eat disorder , bulimia ; Pregnancy , breast feeding , intention become pregnant study ( female childbearing potential ; Current enrollment investigational drug device study participation study within 30 day entry study ; Poor general health , presence specific condition , situation , Evaluating and/or Placing Investigator 's opinion may put subject significant risk , may confound study result , may increase risk associated endoscopy and/or placement BIB , may interfere significantly subject 's participation study ( e.g. , HIV , Hepatitis C , cancer history within last 5 year )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>